Novocure's cancer treatment fails to meet late-stage trial goal
18/06/2026 12:06
Novocure's cancer treatment fails to meet late-stage trial goal June 18 (Reuters) - Novocure NVCR.O said on Thursday that its cancer treatment for newly diagnosed brain tumors did not meet the main goal of a late-stage study.
(Reporting by Sneha S K; Editing by Tasim Zahid)
Recent news on NovoCure
See all newsOncology firm Novocure says cyberattack exposed US patient records
Novocure Ltd reports results for the quarter ended June 30 - Earnings Summary
Novocure Q2 revenue beats, lifts 2026 outlook
Brief: Novocure Q2 Revenue USD 183.584 Million Vs. IBES Estimate USD 172.4 Million
U.S. STOCKS ON THE MOVE-Kardigan, Energy companies, Take-Two, Accenture